These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12297808)

  • 1. Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin.
    Sher LD; Poole MD; Von Seggern K; Wikler MA; Nicholson SC; Pankey GA
    Otolaryngol Head Neck Surg; 2002 Sep; 127(3):182-9. PubMed ID: 12297808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral gatifloxacin in outpatient community-acquired pneumonia: results from TeqCES, a community-based, open-label, multicenter study.
    Gotfried M; Quinn TC; Gothelf S; Wikler MA; Webb CD; Nicholson SC
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):85-91. PubMed ID: 12376037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter evaluation of the efficacy and safety of gatifloxacin in Mexican adult outpatients with respiratory tract infections.
    Casillas JL; Rico G; Rodríguez-Parga D; Mascareño A; Rangel-Frausto S
    Adv Ther; 2000; 17(6):263-71. PubMed ID: 11317829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of gatifloxacin in community treatment of acute exacerbations of chronic bronchitis.
    Anzueto A; Gotfried M; Wikler MA; Russo R; Nicholson SC
    Clin Ther; 2002 Jun; 24(6):906-17. PubMed ID: 12117081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infections.
    Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):77-84. PubMed ID: 12376036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumonia.
    Nicholson SC; Wilson WR; Naughton BJ; Gothelf S; Webb CD
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):117-25. PubMed ID: 12376041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open multicenter study of the use of gatifloxacin for the treatment of non-complicated acute bacterial rhinosinusitis in adults.
    Weckx LL; Campos CA; Sakano E; Pignatari SS; Figueiredo CR
    Braz J Infect Dis; 2005 Apr; 9(2):162-8. PubMed ID: 16127593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Sydnor TA; Kopp EJ; Anthony KE; LoCoco JM; Kim SS; Fowler CL
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderly.
    Nicholson SC; High KP; Gothelf S; Webb CD
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):109-16. PubMed ID: 12376040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae.
    Jones RN; Andes DR; Mandell LA; Gothelf S; Ehrhardt AF; Nicholson SC
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):93-100. PubMed ID: 12376038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pathogen spectrum of acute bacterial rhinitis/sinusitis and antibiotic resistance].
    Fickweiler U; Fickweiler K
    HNO; 2005 Aug; 53(8):735-40. PubMed ID: 15702353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open label, multicenter, non-comparative study of the efficacy and safety of oral gatifloxacin in the treatment of community-acquired pneumonia: a Brazilian study in five centers.
    Nicodemo AC
    Braz J Infect Dis; 2003 Feb; 7(1):62-8. PubMed ID: 12807692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of acute bacterial rhinosinusitis and the role of moxifloxacin.
    Anon JB
    Clin Infect Dis; 2005 Jul; 41 Suppl 2(Suppl 2):S167-76. PubMed ID: 15942883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gatifloxacin: a review of its use in the management of bacterial infections.
    Perry CM; Ormrod D; Hurst M; Onrust SV
    Drugs; 2002; 62(1):169-207. PubMed ID: 11790160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management.
    Anon JB
    Paediatr Drugs; 2003; 5 Suppl 1():25-33. PubMed ID: 14632103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia.
    Mandell LA; Jones RN
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):127-8. PubMed ID: 12376042
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy/safety of amoxicillin/clavulanate in adults with bacterial rhinosinusitis.
    Anon JB; Berkowitz E; Breton J; Twynholm M
    Am J Otolaryngol; 2006; 27(4):248-54. PubMed ID: 16798401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of gatifloxacin in community-acquired pneumonia: rationale for the Tequin Clinical Experience Study (TeqCES).
    Mandell LA
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):65-7. PubMed ID: 12376034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.